Annovis Bio: Moving Forward Against Parkinson's

[Farooqji]

Last week the company disclosed that enrollment into its Phase 3 PD trial for buntanetap was going well and based on the pace of this effort, an interim data analysis from this study should be out sometime in the second quarter of this year. This obviously could be a key near term milestone on the horizon.

seekingalpha.com/article/45...

[jeffmayer]

Could this mean a cure

[Farooqji in reply to jeffmayer]

its still phase result. Nothing can be concluded yet

[Canddy]

I really really hope the Phase 3 results are positive and the drug is safe. If so, I hope this leads to accelerated approval of this drug.

[limcheeese22]

I wonder why higher dose lesser effect, at 80mg almost no effect. And the results only 25 days, does that higher dose OR longer period the effect will be gone? Hopefully not.